Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel TAP Block for Abdominal Wall Reconstruction
NCT02274077Phase 4Withdrawn
- Sponsor
- Chester Mays
- Start
- Jan 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in ventral hernia, sponsored by Chester Mays. Planned start Jan 2016; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
ventral hernia
Beyond the preview
Go deeper on NCT02274077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02274077.